ARS Debt To Assets from 2010 to 2025

SPRY Stock   11.65  0.01  0.09%   
ARS Pharmaceuticals, Debt To Assets yearly trend continues to be fairly stable with very little volatility. Debt To Assets will likely drop to 0.0001 in 2025. During the period from 2010 to 2025, ARS Pharmaceuticals, Debt To Assets regression line of annual values had r-squared of  0.12 and arithmetic mean of  0.25. View All Fundamentals
 
Debt To Assets  
First Reported
2010-12-31
Previous Quarter
0.00011961
Current Value
0.000114
Quarterly Volatility
0.23721038
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ARS Pharmaceuticals, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ARS Pharmaceuticals,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 75 K, Gross Profit of 72 M or Other Operating Expenses of 96.8 M, as well as many indicators such as Price To Sales Ratio of 10.9, Dividend Yield of 0.0 or PTB Ratio of 3.78. ARS financial statements analysis is a perfect complement when working with ARS Pharmaceuticals, Valuation or Volatility modules.
  
Build AI portfolio with ARS Stock
Check out the analysis of ARS Pharmaceuticals, Correlation against competitors.
For more information on how to buy ARS Stock please use our How to Invest in ARS Pharmaceuticals, guide.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for ARS Stock Analysis

When running ARS Pharmaceuticals,'s price analysis, check to measure ARS Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ARS Pharmaceuticals, is operating at the current time. Most of ARS Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of ARS Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ARS Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of ARS Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.